RecruitingNCT05867849
Cannabidiol for Depression in bipolarity (CBD-BD)
Medication studyAges 19–70Canada
Understand this study
Who could participate?
Listed age limits: 19 years to 70 years.
- Listed locations
- Vancouver and 5 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: October 15, 2023
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 360
- Sponsor
- University of British Columbia
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Canada
- Age range
- From 19 Years to 70 Years
- Official registry ID
- NCT05867849
- Official title
Show the full official title
Cannabidiol Adjunctive Therapy for Acute Bipolar Depression: A Randomized Double-Blind, Placebo Controlled Trial
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Vancouver · Hamilton · Kingston
2 more locations
- Toronto
- Montreal
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of British Columbia, a university.
Does this study involve medication?
Yes. The study involves medication, including Cannabidiol.
Who can participate?
Listed age limits: 19 years to 70 years.
Is this study still recruiting?
The registry lists this study as recruiting.
